Old National Bancorp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $686K | Buy |
13,082
+3,848
| +42% | +$204K | 0.01% | 336 |
|
|
2026
Q1 | $510K | Hold |
9,234
| – | – | 0.01% | 400 |
|
|
2025
Q4 | $453K | Sell |
9,234
-946
| -9% | -$44.1K | 0.01% | 406 |
|
|
2025
Q3 | $439K | Hold |
10,180
| – | – | 0.01% | 408 |
|
|
2025
Q2 | $391K | Buy |
10,180
+1,074
| +12% | +$41K | 0.01% | 414 |
|
|
2025
Q1 | $353K | Sell |
9,106
-2,000
| -18% | -$73.2K | 0.01% | 378 |
|
|
2024
Q4 | $376K | Buy |
11,106
+1,332
| +14% | +$48K | 0.01% | 445 |
|
|
2024
Q3 | $400K | Sell |
9,774
-32
| -0.3% | -$1.31K | 0.01% | 437 |
|
|
2024
Q2 | $378K | Sell |
9,806
-544
| -5% | -$22.9K | 0.01% | 426 |
|
|
2024
Q1 | $444K | Hold |
10,350
| – | – | 0.01% | 391 |
|
|
2023
Q4 | $384K | Sell |
10,350
-2,000
| -16% | -$71.8K | 0.01% | 422 |
|
|
2023
Q3 | $448K | Buy |
12,350
+1,498
| +14% | +$53.2K | 0.01% | 412 |
|
|
2023
Q2 | $387K | Buy |
10,852
+850
| +8% | +$30.5K | 0.01% | 458 |
|
|
2023
Q1 | $356K | Sell |
10,002
-584
| -6% | -$20.4K | 0.01% | 489 |
|
|
2022
Q4 | $372K | Buy |
10,586
+262
| +3% | +$8.73K | 0.01% | 485 |
|
|
2022
Q3 | $304K | Buy |
10,324
+602
| +6% | +$22.8K | 0.01% | 522 |
|
|
2022
Q2 | $529K | Sell |
9,722
-47
| -0.5% | -$2.6K | 0.02% | 393 |
|
|
2022
Q1 | $532K | Buy |
9,769
+59
| +0.6% | +$3.21K | 0.02% | 340 |
|
|
2021
Q4 | $535K | Buy |
9,710
+60
| +0.6% | +$3.12K | 0.02% | 329 |
|
|
2021
Q3 | $461K | Buy |
9,650
+182
| +2% | +$9.14K | 0.02% | 351 |
|
|
2021
Q2 | $471K | Sell |
9,468
-400
| -4% | -$19.2K | 0.02% | 350 |
|
|
2021
Q1 | $440K | Sell |
9,868
-9,122
| -48% | -$414K | 0.02% | 375 |
|
|
2020
Q4 | $874K | Buy |
18,990
+5
| +0% | +$230 | 0.04% | 269 |
|
|
2020
Q3 | $893K | Sell |
18,985
-357
| -2% | -$17.9K | 0.04% | 245 |
|
|
2020
Q2 | $986K | Sell |
19,342
-6,383
| -25% | -$327K | 0.05% | 225 |
|
|
2020
Q1 | $1.22M | Buy |
25,725
+8,771
| +52% | +$468K | 0.08% | 198 |
|
|
2019
Q4 | $996K | Buy |
16,954
+6,463
| +62% | +$360K | 0.05% | 243 |
|
|
2019
Q3 | $560K | Hold |
10,491
| – | – | 0.03% | 307 |
|
|
2019
Q2 | $525K | Sell |
10,491
-339
| -3% | -$17K | 0.03% | 323 |
|
|
2019
Q1 | $566K | Sell |
10,830
-733
| -6% | -$36.6K | 0.03% | 307 |
|
|
2018
Q4 | $552K | Sell |
11,563
-771
| -6% | -$38K | 0.03% | 311 |
|
|
2018
Q3 | $619K | Sell |
12,334
-1,291
| -9% | -$65.6K | 0.03% | 330 |
|
|
2018
Q2 | $686K | Buy |
13,625
+1,230
| +10% | +$62K | 0.04% | 302 |
|
|
2018
Q1 | $605K | Hold |
12,395
| – | – | 0.03% | 324 |
|
|
2017
Q4 | $550K | Sell |
12,395
-80
| -0.6% | -$3.7K | 0.03% | 345 |
|
|
2017
Q3 | $633K | Hold |
12,475
| – | – | 0.03% | 301 |
|
|
2017
Q2 | $672K | Sell |
12,475
-1,568
| -11% | -$83.6K | 0.04% | 291 |
|
|
2017
Q1 | $740K | Sell |
14,043
-6,251
| -31% | -$317K | 0.04% | 283 |
|
|
2016
Q4 | $977K | Sell |
20,294
-588
| -3% | -$29K | 0.06% | 249 |
|
|
2016
Q3 | $1.13M | Sell |
20,882
-1,592
| -7% | -$87.3K | 0.06% | 220 |
|
|
2016
Q2 | $1.22M | Buy |
22,474
+6,384
| +40% | +$336K | 0.07% | 203 |
|
|
2016
Q1 | $815K | Sell |
16,090
-558
| -3% | -$27.8K | 0.05% | 257 |
|
|
2015
Q4 | $840K | Sell |
16,648
-1,114
| -6% | -$56.8K | 0.05% | 248 |
|
|
2015
Q3 | $854K | Sell |
17,762
-991
| -5% | -$51.6K | 0.05% | 233 |
|
|
2015
Q2 | $976K | Sell |
18,753
-11,798
| -39% | -$664K | 0.05% | 230 |
|
|
2015
Q1 | $1.76M | Buy |
30,551
+9,945
| +48% | +$570K | 0.1% | 164 |
|
|
2014
Q4 | $1.1M | Buy |
20,606
+45
| +0.2% | +$2.52K | 0.07% | 180 |
|
|
2014
Q3 | $1.18M | Sell |
20,561
-293
| -1% | -$18K | 0.08% | 175 |
|
|
2014
Q2 | $1.39M | Buy |
20,854
+2,754
| +15% | +$186K | 0.11% | 132 |
|
|
2014
Q1 | $1.21M | Buy |
18,100
+936
| +5% | +$63.3K | 0.11% | 113 |
|
|
2013
Q4 | $1.15M | Sell |
17,164
-78
| -0.5% | -$5.06K | 0.1% | 88 |
|
|
2013
Q3 | $1.08M | Buy |
17,242
+406
| +2% | +$26.1K | 0.11% | 81 |
|
|
2013
Q2 | $1.05M | Buy |
+16,836
| New | +$1.07M | 0.11% | 84 |
|
Other funds holding GSK
LMFP
DLA
TNB
AA
CFM
FVWA
SIS
KFP
QCM
TH
Old National Bancorp's GSK Position: Q2 2026 in Review
Old National Bancorp increased its GSK (GSK) stake by 42% in Q2 2026, buying an estimated $204K and bringing the position to 13,082 shares worth $686K. The position accounts for 0.01% of the portfolio, ranked #336.
Old National Bancorp first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.76M in Q1 2015. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Old National Bancorp held 13,082 shares of GSK worth $686K as of Q2 2026.
- Old National Bancorp bought 3,848 GSK shares in Q2 2026, an estimated $204K.
- GSK made up 0.01% of Old National Bancorp's portfolio in Q2 2026, its #336 holding.
- Old National Bancorp first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Old National Bancorp's GSK position peaked at $1.76M in Q1 2015.
- 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.